Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Francesco A. Logoluso"'
Autor:
Vincenzo Nuzzo, Roberta Modica, Valentina Guarnotta, Antongiulio Faggiano, Pasqualino Malandrino, Vincenzo Nicastro, Marcello Sciaraffia, Francesco A. Logoluso, Ernesto A. Giordano, Maurizio Aversano, Annamaria Colao, Daniela Agrimi, V. Bassi, Erika Messina
BACKGROUND Everolimus, an oral mTOR (mammalian target of rapamycin) inhibitor, is currently approved for the treatment of progressive pancreatic neuroendocrine tumors (NETs). Although promising, only scattered data, often from nondedicated studies, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500ed7b1bfc254a418a60dbbd1169812
http://hdl.handle.net/11573/1286186
http://hdl.handle.net/11573/1286186
